Risks overview
A balanced overview of the main risks of breast implant surgery, from early complications to long-term issues, and why informed consent matters.
Implant safety is not a single yes-or-no. It is a set of known, quantified risks — some common and manageable, some rare and serious — against benefits that many patients find worthwhile. Reading them honestly is the basis of informed consent.
The main risks
What can happen, and how common it is
| Risk | What it is | What to understand |
|---|---|---|
| Capsular contracture | Tightening of the scar capsule around the implant | The most common reason for revision; can cause firmness, distortion and discomfort. Textured surfaces were introduced partly to reduce it. |
| Rupture / silent rupture | Loss of implant integrity | Silicone rupture may cause no symptoms, which is why screening is recommended; saline rupture is usually obvious as the breast deflates. |
| BIA-ALCL | Breast implant-associated anaplastic large cell lymphoma | A rare lymphoma of the fluid or capsule, linked mainly to textured implants. It is treatable, particularly when caught early. |
| BIA-SCC | Breast implant-associated squamous cell carcinoma | A very rare cancer in the capsule; regulators list it alongside ALCL as a device-associated risk. |
| Infection | Infection around the implant | May require antibiotics and, in some cases, implant removal. |
| Systemic symptoms (“BII”) | Self-reported fatigue, “brain fog”, joint pain and rash | Widely reported but not an established diagnosis; reviews find the correlation with implants is not established and evidence is limited. |
| Sensation & breastfeeding changes | Altered nipple or skin sensation; effects on feeding | Varies with technique and individual anatomy; discussed before consent. |
| Need for revision | Further surgery at some point | Reported revision rates after primary augmentation are as high as 36%. |
Monitoring, not reassurance
For silicone implants the FDA recommends MRI or ultrasound at five to six years after placement and then every two to three years, because a ruptured implant can produce no symptoms. Ongoing monitoring is part of living with implants — not a sign that something has gone wrong.
What the systematic reviews show
The Cochrane Library holds independent systematic reviews and registered protocols on breast implants, wound drains, implant types and reconstruction. Systematic reviews pool many studies and sit at the top of the evidence ladder, which makes them the most reliable single guide to what is known and, equally importantly, to where the evidence is still missing.
The literature also documents past device failures and withdrawals — from PIP implants, with their increased rupture and leakage risk, to the soybean-oil-filled Trilucent implants that were withdrawn because of lipid-oxidation metabolites. These episodes are why modern regulators require long-term data and registries.
Injectable silicone and fillers
Importantly, most of the serious “breast filler” harms in the literature are not about implants at all. They concern injectable fillers and liquid silicone used to enlarge the breast off-label — products that can migrate, cause infection, granulomas and disfigurement, and interfere with mammography. The safest position on injectable fillers and silicone in the breast is the regulator position: do not use them for this purpose.
Regulator and systematic-review sources
U.S. Food and Drug Administration (FDA) — www.fda.gov/
- Breast Implants (Regulatory hub)
- Types of Breast Implants (Regulatory page)
- Risks and Complications of Breast Implants (Regulatory page)
- Things to Consider Before Getting Breast Implants (Patient decision guide)
- Breast Implant Surgery (Regulatory page)
- Breast Implants — Certain Labeling Recommendations to Improve Patient Communication (FDA guidance (2020))
- …and 10 more in the full library.
Cochrane Library (Cochrane Database of Systematic Reviews) — www.cochranelibrary.com/
- Wound drainage after plastic and reconstructive surgery of the breast (Cochrane Review)
- Different types of implants for reconstructive breast surgery (Cochrane Review)
- Implants versus autologous tissue flaps for breast reconstruction following mastectomy (Cochrane Review)
- Breast implant insertion funnels for preventing capsular contracture (Cochrane Protocol)
- Mesh for immediate implant-based prepectoral breast reconstruction following mastectomy (Cochrane Protocol)
- Acellular dermal matrices for breast reconstruction surgery (Cochrane Protocol)
- …and 1 more in the full library.
Educational information only
This page summarises published evidence and regulator guidance for general education. It cannot account for your health or circumstances and does not recommend any treatment. Discuss any symptom after a procedure promptly with a qualified clinician.
Implant risks, rupture and complications in more detail
Implant rupture
How breast implants can rupture or leak, why silicone ruptures may go unnoticed, how they are detected and what happens next.
Sensation changes
Why feeling in the nipple and breast can change after implant surgery, how common it is, how long it lasts and when to seek advice.
Early complications
Understand infection, bleeding (haematoma) and fluid collection (seroma) after breast implant surgery, including warning signs and treatment.
Who should delay or avoid implants
Situations in which breast implants may be unsuitable or better delayed, including health, lifestyle and expectation-related factors.
Continue reading
Related education
Surgical Breast Enlargement
Return to the full category guide.
Safety and warning signs
Candidacy, risks and when to seek medical help.
External research and sources
Study findings, limitations and original publications.